US20110008348A1

US20110008348A1 - Soluble fragments of influenza virus pb2 protein capable of binding rna-cap

Info

Publication number: US20110008348A1
Application number: US12/681,974
Authority: US
Inventors: Stephen Cusack; Delphine Guilligay; Darren Hart; Franck Tarendeau
Original assignee: Individual
Current assignee: Europaisches Laboratorium fuer Molekularbiologie EMBL
Priority date: 2007-07-13
Filing date: 2008-07-11
Publication date: 2011-01-13
Also published as: EP2197901A1; EP2574619A3; SG185289A1; ES2454773T3; JP6309563B2; AU2008309939A1; CA2701362A1; JP5937169B2; IL222997A0; CN101970465B; JP2015062417A; KR101672554B1; IL237903A; IL204891A0; CN101970465A; WO2009046983A1; JP5725861B2; KR20100074212A; US9045248B2; IL204891A

Abstract

A plastic container includes an upper portion having a mouth defining an opening into the container. A shoulder region extends from the upper portion. A sidewall portion extends between the shoulder region and a base portion. The base portion closes off an end of the container. A vacuum panel region defined in part by at least two vacuum panels. Each of the vacuum panels are movable to accommodate vacuum forces generated within the container resulting from heating and cooling of its contents. The vacuum panel region occupies an area outboard of the sidewall portion.

Description

TECHNICAL FIELD

This disclosure generally relates to plastic containers for retaining a commodity, and in particular a liquid commodity. More specifically, this disclosure relates to a plastic container having a vacuum panel region defined on the plastic container in an area distinct from a sidewall having a label panel area.

BACKGROUND

As a result of environmental and other concerns, plastic containers, more specifically polyester and even more specifically polyethylene terephthalate (PET) containers are now being used more than ever to package numerous commodities previously supplied in glass containers. Manufacturers and fillers, as well as consumers, have recognized that PET containers are lightweight, inexpensive, recyclable and manufacturable in large quantities.
Blow-molded plastic containers have become commonplace in packaging numerous commodities. PET is a crystallizable polymer, meaning that it is available in an amorphous form or a semi-crystalline form. The ability of a PET container to maintain its material integrity relates to the percentage of the PET container in crystalline form, also known as the “crystallinity” of the PET container. The following equation defines the percentage of crystallinity as a volume fraction:
$% Crystallinity = (\frac{ρ - ρ_{a}}{ρ_{c} - ρ_{a}}) \times 100$
where ρ is the density of the PET material; ρ_ais the density of pure amorphous PET material (1.333 g/cc); and ρ_cis the density of pure crystalline material (1.455 g/cc).
Container manufacturers use mechanical processing and thermal processing to increase the PET polymer crystallinity of a container. Mechanical processing involves orienting the amorphous material to achieve strain hardening. This processing commonly involves stretching an injection molded PET preform along a longitudinal axis and expanding the PET preform along a transverse or radial axis to form a PET container. The combination promotes what manufacturers define as biaxial orientation of the molecular structure in the container. Manufacturers of PET containers currently use mechanical processing to produce PET containers having approximately 20% crystallinity in the container's sidewall.
Thermal processing involves heating the material (either amorphous or semi-crystalline) to promote crystal growth. On amorphous material, thermal processing of PET material results in a spherulitic morphology that interferes with the transmission of light. In other words, the resulting crystalline material is opaque, and thus, generally undesirable. Used after mechanical processing, however, thermal processing results in higher crystallinity and excellent clarity for those portions of the container having biaxial molecular orientation. The thermal processing of an oriented PET container, which is known as heat setting, typically includes blow molding a PET preform against a mold heated to a temperature of approximately 250° F.-350° F. (approximately 121° C.-177° C.), and holding the blown container against the heated mold for approximately two (2) to five (5) seconds. Manufacturers of PET juice bottles, which must be hot-filled at approximately 185° F. (85° C.), currently use heat setting to produce PET bottles having an overall crystallinity in the range of approximately 25%-35%.
After being hot-filled, the heat-set containers may be capped and allowed to reside at generally the filling temperature for approximately five (5) minutes at which point the container, along with the product, is then actively cooled prior to transferring to labeling, packaging, and shipping operations. The cooling reduces the volume of the liquid in the container. This product shrinkage phenomenon results in the creation of a vacuum within the container. Generally, vacuum pressures within the container range from 1-380 mm Hg less than atmospheric pressure (i.e., 759 mm Hg-380 mm Hg). If not controlled or otherwise accommodated, these vacuum pressures result in deformation of the container, which leads to either an aesthetically unacceptable container or one that is unstable. Hot-fillable plastic containers must provide sufficient flexure to compensate for the changes of pressure and temperature, while maintaining structural integrity and aesthetic appearance. Typically, the industry accommodates vacuum related pressures with sidewall structures or vacuum panels formed within the sidewall of the container. Such vacuum panels generally distort inwardly under vacuum pressures in a controlled manner to eliminate undesirable deformation.
While such vacuum panels allow containers to withstand the rigors of a hot-fill procedure, the panels have limitations and drawbacks. First, such panels formed within the sidewall of a container do not create a generally smooth glass-like appearance. Second, packagers often apply a wrap-around or sleeve label to the container over these panels. The appearance of these labels over the vacuum panels is such that the label often becomes wrinkled and not smooth. Additionally, one grasping the container generally feels the vacuum panels beneath the label and often pushes the label into various panel crevasses and recesses.

SUMMARY

A plastic container includes an upper portion having a mouth defining an opening into the container. A shoulder region extends from the upper portion. A sidewall portion extends between the shoulder region and a base portion. The base portion closes off an end of the container. A vacuum panel region is defined in part by at least two vacuum panels. Each of the vacuum panels are movable to accommodate vacuum forces generated within the container resulting from heating and cooling of its contents. The vacuum panel region occupies an area outboard of the sidewall portion.
According to additional features, the vacuum panels each define a plane that is substantially parallel to a longitudinal axis of the plastic container. The vacuum panels can be generally rectangular shaped. In one example, the vacuum panels include three pair of vacuum panels. Each vacuum panel opposes a corresponding vacuum panel. The sidewall portion includes a series of horizontal ribs that substantially circumscribe a perimeter of the sidewall portion.
According to another example, the vacuum panel region can comprise a first vacuum panel region and a second vacuum panel region. The sidewall portion is formed intermediate of the first and second vacuum panel regions. Both of the first and second vacuum panel regions define three pair of vacuum panels.
Additional benefits and advantages of the present disclosure will become apparent to those skilled in the art to which the present disclosure relates from the subsequent description and the appended claims, taken in conjunction with the accompanying drawings.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a perspective view of a plastic container constructed in accordance with the teachings of the present disclosure.

FIG. 2 is a side elevational view of the plastic container of FIG. 1.

FIG. 3 is a top view of the plastic container of FIG. 1.

FIG. 4 is a cross-sectional view of the plastic container taken along line 4-4 of FIG. 1.

FIG. 5 is a perspective view of a plastic container constructed in accordance with additional teachings of the present disclosure.

FIG. 6 is a side elevational view of the plastic container of FIG. 5.

FIG. 7 is a top view of the plastic container of FIG. 5; and

FIG. 8 is a cross-sectional view of the plastic container taken along line 8-8 of FIG. 5.

DETAILED DESCRIPTION

The following description is merely exemplary in nature, and is in no way intended to limit the disclosure or its application or uses.
With reference to FIGS. 1-4, a plastic, e.g. polyethylene terephthalate (PET), hot-fillable container according to the present teachings is shown and generally identified at reference number 10. As shown in FIG. 2, the plastic container 10 has an overall height H₁of about 190.3 mm (7.49 inches). The height H₁may be selected so that the plastic container 10 fits on the shelves of a supermarket or store. In this particular embodiment, the plastic container 10 has a volume capacity of about 20 fl. oz. (591 cc). Those of ordinary skill in the art would appreciate that the following teachings are applicable to other containers, such as containers having different shapes, which may have different dimensions and volume capacities. It is also contemplated that other modifications can be made depending on the specific application and environmental requirements.
The plastic container 10 according to the present teachings defines a body 12 and includes an upper portion 14 having a finish 16. Integrally formed with the finish 16 and extending downward therefrom is a shoulder region 20. The shoulder region 20 merges into and provides a transition between the finish 16 and a sidewall portion 22. The sidewall portion 22 extends downward from the shoulder region 20 to a vacuum panel region 26. The vacuum panel region 26 merges into a base portion 28 having a base 30. A neck 32 may also be included having an extremely short height, that is, becoming a short extension from the finish 16, or an elongated height, extending between the finish 16 and the shoulder region 20. The plastic container 10 has been designed to retain a commodity. The commodity may be in any form such as a solid or liquid product. In one example, a liquid commodity may be introduced into the plastic container 10 during a thermal process, typically a hot-fill process. For hot-fill bottling applications, bottlers generally fill the plastic container 10 with a liquid or product at an elevated temperature between approximately 155° F. to 205° F. (approximately 68° C. to 96° C.) and seal the plastic container 10 with a cap (not illustrated) before cooling. In addition, the plastic container 10 may be suitable for other high-temperature pasteurization or retort filling processes or other thermal processes as well. In another example, the commodity may be introduced into the plastic container 10 under ambient temperatures.
The finish 16 of the plastic container 10 includes a portion defining an aperture or mouth 36, and a threaded region 38 having threads 40. The finish 16 can also define a support ring 42. The support ring 42 may be used to carry or orient a preform (the precursor to the plastic container 10, not illustrated) through and at various stages of manufacture. For example, the preform may be carried by the support ring 42, the support ring 42 may be used to aid in positioning the preform in the mold, or an end consumer may use the support ring 42 to carry the plastic container 10 once manufactured.
The aperture 36 allows the plastic container 10 to receive a commodity while the threaded region 38 provides a means for attachment of a similarly threaded closure or cap (not illustrated). Alternatives may include other suitable devices that engage the finish 16 of the plastic container 10. Accordingly, the closure or cap (not illustrated) engages the finish 16 to preferably provide a hermetical seal of the plastic container 10. The closure or cap (not illustrated) is preferably of a plastic or metal material conventional to the closure industry and suitable for subsequent thermal processing, including high temperature pasteurization and retort.
The sidewall portion 22 includes a series of horizontal ribs 44. The horizontal ribs 44 substantially circumscribe the entire perimeter of the sidewall portion 22 of the plastic container 10. The horizontal ribs 44 extend continuously in a longitudinal direction from the shoulder region 20 to the vacuum panel region 26. According to one example, the sidewall portion 22 can define a width W₅. The width W₅can be approximately 60 mm (2.36 inches). The base 30 functions to close off the base portion 28 of the plastic container 10 and, together with the finish 16, the shoulder region 20, the sidewall portion 22, and the vacuum panel region 26, to retain the commodity. The base portion 28 generally defines an outer surface having a thread detail 48 formed therearound. The thread detail 48 can assist in providing structural integrity to the base portion 28 as well as provide an ornamental appeal to the plastic container 10. Additionally, the thread detail 48 may facilitate attachment of a secondary container or closure.
The vacuum panel region 26 is generally defined between lateral surfaces 50 at a stepped-out portion 52 of the plastic container 10. The vacuum panel region 26 defines a plurality of vacuum panels 56 generally extending on respective planes that are parallel to a central longitudinal axis 60 of the plastic container 10. According to one example, the stepped-out portion 52 can define a width W₁between opposing vacuum panels 56. The width W₁can be approximately 85 mm (3.35 inches). Preferably, the width W₁may be at least 10% greater than the width W₅. More preferably, the width W₁may be about 20%-40% greater than the width W₅.
As illustrated in FIGS. 1-4, the vacuum panels 56 may be generally rectangular in shape. It is appreciated that the vacuum panels 56 may define other geometrical configurations as well. Accordingly, the plastic container 10 illustrated in the FIGS. 1-4 has six (6) vacuum panels 56. The inventors however equally contemplate that more than or less than six (6) vacuum panels 56 can be provided. By way of example, the vacuum panel region 26 can also be formed on the plastic container 10 having two (2), three (3), four (4), five (5), seven (7) or eight (8) vacuum panels. As illustrated, the present teachings facilitate the orientation of vacuum panels 56 in a horizontal direction relative to the central longitudinal axis 60 of the plastic container 10. Surrounding the vacuum panels 56 are horizontal and vertical connecting walls 62 and 64, respectively. Each horizontal connecting wall 62 is generally defined between the vacuum panel 56 and respective lateral surfaces 50. The horizontal connecting walls 62 define a generally arcuate profile in horizontal cross-section (see FIG. 4). Each vertical connecting wall 64 is defined between adjacent vacuum panels 56.
Optionally, each horizontal connecting wall 62 may define a distinctly identifiable structure between the lateral surfaces 50 and an underlying surface 66 of vacuum panels 56. The horizontal connecting walls 62 provide strength to the transition between the lateral surfaces 50 and the underlying surface 66 of the vacuum panels 56. The resulting localized strength increases the resistance to creasing and denting in the vacuum panel region 26 and the plastic container 10 as a whole.
A label panel area 70 is defined at the sidewall portion 22. The label panel area 70 therefore occupies a distinct portion of the plastic container 10 relative to the vacuum panel region 26. As is commonly known and understood by container manufacturers skilled in the art, a label (not shown) may be applied to the sidewall portion 22 (label panel area 70) using methods that are well known to those skilled in the art, including shrink-wrap labeling and adhesive methods. As applied, the label may extend around the entire body 12 or be limited to a partial circumference of the sidewall portion 22.
Upon filling, capping, sealing and cooling, as illustrated in FIG. 4 in phantom, the horizontal connecting walls 62 each act as a hinge that aids in the allowance of the underlying surface 66 of vacuum panels 56 to be pulled radially inward, toward the central longitudinal axis 60 of the plastic container 10, displacing volume, as a result of vacuum forces. In this position, the underlying surface 66 of vacuum panels 56, in cross section, illustrated in FIG. 4 in phantom, forms a generally concave surface 66′. The configuration of the sidewall portion 22 and the vacuum panel region 26, allow the vacuum reaction to be absorbed in a controlled manner by the vacuum panels 56 without substantial disruption to the label panel area 70 or a remainder of the plastic container 10.
As illustrated in FIG. 2, the vacuum panels 56 have a width W₂. In one example, for the plastic container 10 having a nominal capacity of approximately 16.9 fl. oz. (500 cc), the width W₂may be about 43.81 mm (1.72 inches). A height H₂defined at an outermost edge of the vacuum panels 56 may be about 27.16 mm (1.07 inches). The height H₂may vary slightly across the width W₂of the vacuum panels 56. A height H₃defined from the shoulder region 20 to a transition between the sidewall portion 22 and the vacuum panel region 26 may be about 74.33 mm (2.93 inches). A height H₄of the finish 16 may be about 19.71 mm (0.76 inch). A height H₅of the base portion 28 may be about 48.08 mm (1.89 inches).
With reference to FIGS. 5-8, a plastic, e.g. polyethylene terephthalate (PET), hot-fillable container according to the present teachings is shown and generally identified at reference number 110. As shown in FIG. 6, the plastic container 110 has an overall height H₆of about 262.92 mm (10.35 inches). The height H₆may be selected so that the plastic container 110 fits on the shelves of a supermarket or store. Again, it is contemplated that other modifications can be made depending on the specific application.
The plastic container 110 according to the present teachings defines a body 112 and includes an upper portion 114 having a finish 116. Integrally formed with the finish 116 and extending downward therefrom is a shoulder region 120. The shoulder region 120 merges into and provides a transition between the finish 116 and a first vacuum panel region 118. The first vacuum panel region 118 merges into a sidewall portion 122. The sidewall portion 122 extends downward from the first vacuum panel region 118 to a second vacuum panel region 126. The second vacuum panel region 126 can transition into a base portion 128 having a base 130. A neck 132 may also be included having an extremely short height, that is, becoming a short extension from the finish 116, or an elongated height, extending between the finish 116 and the shoulder region 120. The plastic container 110 has been designed to retain a commodity. The commodity may be in any form such as a solid or liquid product. In one example, a liquid commodity may be introduced into the plastic container 110 during a thermal process, typically a hot-fill process, such as described above. In another example, the commodity may be introduced into the plastic container 110 under ambient temperatures.
The finish 116 of the plastic container 110 includes a portion defining an aperture or mouth 136, and a threaded region 138 having threads 140. The finish 116 can also define a support ring 142. The support ring 142 may be used to carry or orient a preform (the precursor to the plastic container 110, not illustrated) through and at various stages of manufacture. For example, the preform may be carried by the support ring 142, the support ring 142 may be used to aid in positioning the preform in the mold, or an end consumer may use the support ring 142 to carry the plastic container 110 once manufactured.
The aperture 136 allows the plastic container 110 to receive a commodity while the threaded region 138 provides a means for attachment of a similarly threaded closure or cap (not illustrated). Accordingly, the closure or cap (not illustrated) engages the finish 116 to preferably provide a hermetical seal of the plastic container 110. The closure or cap (not illustrated) is preferably of a plastic or metal material conventional to the closure industry and suitable for subsequent thermal processing, including high temperature pasteurization and retort.
The sidewall portion 122 includes a series of horizontal ribs 144. The horizontal ribs 144 circumscribe the entire perimeter of the sidewall portion 122 of the plastic container 110. The horizontal ribs 144 extend continuously in a longitudinal direction from the first vacuum panel region 118 to the second vacuum panel region 126. According to one example, the sidewall portion 122 can define a width W₆. The width W₆can be approximately 50.8 mm (2.0 inches). The base 130 functions to close off the base portion 128 of the plastic container 110 and, together with the finish 116, the shoulder region 120, the sidewall portion 122, and the first and second vacuum panel regions 118 and 126, respectively, to retain the commodity.
The first and second vacuum panel regions 118 and 126 are generally defined at first and second stepped-out portions 152 and 154, respectively, of the plastic container 110. The figures and the following description are directed toward first and second vacuum panel regions that are substantially equivalent in formation, however, they may be formed differently from each other. The first and second vacuum panel regions 118 and 126 each define a plurality of vacuum panels 156 and 158, respectively, generally extending on respective planes that are parallel to a central longitudinal axis 160 of the plastic container 110. According to one example, the stepped-out portions 152 and 154 can define a width W₃between opposing vacuum panels 156 (and likewise, opposing vacuum panels 158). The width W₃can be approximately 67.06 mm (2.64 inches). As in the previous example, preferably, the width W₃may be at least 10% greater than the width W₆. More preferably, the width W₃may be about 20%-40% greater than the width W₆.
As illustrated in FIGS. 5-8, the vacuum panels 156 and 158 may be generally rectangular in shape. It is appreciated that the vacuum panels 156 and 158 may define other geometrical configurations as well. Accordingly, the plastic container 110 illustrated in the FIGS. 5-8 has six (6) vacuum panels 156 defined on the first vacuum panel region 118, and six (6) vacuum panels 158 defined on the second vacuum panel region 126. The inventors however equally contemplate that more than or less than six (6) vacuum panels 156 and 158 can be provided. By way of example, one or both of the first and second vacuum panel regions 118 and 126 can also be formed on the plastic container 110 having two (2), three (3), four (4), five (5), seven (7) or eight (8) vacuum panels. As illustrated, the present teachings facilitate the orientation of vacuum panels 156 and 158 in a horizontal direction relative to the central longitudinal axis 160 of the plastic container 110.
Surrounding the vacuum panels 156 are horizontal and vertical connecting walls 162 and 164, respectively. Each horizontal connecting wall 162 is generally defined between the vacuum panel 156 and an adjacent radial surface 165. The horizontal connecting walls 162 define a generally arcuate profile in horizontal cross-section (see FIG. 8). Each vertical connecting wall 164 is defined between adjacent vacuum panels 156.
Surrounding the vacuum panels 158 are horizontal and vertical connecting walls 167 and 168, respectively. Each horizontal connecting wall 167 is generally defined between the vacuum panel 158 and an adjacent radial surface 169. The horizontal connecting walls 167 define a generally arcuate profile in horizontal cross-section (see FIG. 8). Each vertical connecting wall 168 is defined between adjacent vacuum panels 158.
Optionally, each horizontal connecting wall 162 and 167 may define a distinctly identifiable structure between the adjacent radial surfaces 165 and 169 and an underlying surface 171 and 172 of vacuum panels 156 and 158, respectively. The horizontal connecting walls 162 and 167 provide strength to the transition between the adjacent radial surfaces 165 and 169 and the underlying surfaces 171 and 172. The resulting localized strength increases the resistance to creasing and denting in the first and second vacuum panel regions 118 and 126, and the plastic container 110 as a whole.
A label panel area 180 is defined at the sidewall portion 122. The label panel area 180 therefore occupies a distinct portion of the plastic container 110 relative to the first and second vacuum panel regions 118 and 126. In this example, the label panel area 180 is defined between the first and second vacuum panel regions 118 and 126. As is commonly known and understood by container manufacturers skilled in the art, a label (not shown) may be applied to the sidewall portion 122 (label panel area 180) using methods that are well known to those skilled in the art, including shrink-wrap labeling and adhesive methods. As applied, the label may extend around the entire body 112 or be limited to a partial circumference of the sidewall portion 122.
Upon filling, capping, sealing and cooling, as illustrated in FIG. 8 in phantom, the horizontal connecting walls 162 and 167 each act as a hinge that aids in the allowance of the underlying surface 171 and 172 of vacuum panels 156 and 158 to be pulled radially inward, toward the central longitudinal axis 160 of the plastic container 110, displacing volume, as a result of vacuum forces. In this position, the underlying surface 171 and 172 of vacuum panels 156 and 158, in cross section, illustrated in FIG. 8 in phantom, form a generally concave surface 171′ and 172′, respectively. The configuration of the sidewall portion 122 and the first and second vacuum panel regions 118 and 126, allow the vacuum reaction to be absorbed in a controlled manner by the vacuum panels 156 and 158 without substantial disruption to the label panel area 180 or a remainder of the plastic container 110.
As illustrated in FIG. 6, the vacuum panels 156 and 158 have a width W₄. In one example, for the plastic container 110 having a nominal capacity of approximately 16.9 fl. oz. (500 cc), the width W₄may be about 34.63 mm (1.36 inches). A height H₇defined at an outermost edge of vacuum panels 156 and 158 may be about 21.16 mm (0.83 inch). The height H₇may vary slightly across the width W₄of the vacuum panels 156 and 158. A height H₈defined by the sidewall portion 122 (label panel area 180) may be about 76.29 mm (3.00 inches). A height H₉of the finish 116 may be about 18.62 mm (0.73 inch). A height H₁₀of the second vacuum panel region 126 and the base portion 128 may be about 74.81 mm (2.95 inches).
While the above description constitutes the present disclosure, it will be appreciated that the disclosure is susceptible to modification, variation and change without departing from the proper scope and fair meaning of the accompanying claims.

Claims

1. A soluble polypeptide fragment, wherein said polypeptide fragment is (i) derived from the Influenza virus RNA-dependent RNA polymerase subunit PB2 or variant thereof and (ii) capable of binding to a RNA cap or analog thereof.

2. The polypeptide fragment of claim 1, wherein said polypeptide fragment is purified to an extent to be suitable for crystallization.

3. The polypeptide fragment of claim 1, wherein the Influenza virus RNA-dependent RNA polymerase subunit PB2 is from an Influenza A, B, or C virus or variant thereof.

4. The polypeptide fragment of claim 1, wherein

(i) the N-terminus is identical to or corresponds to amino acid position 220 or higher and the C-terminus is identical to or corresponds to amino acid position 510 or lower of the amino acid sequence of PB2 according to SEQ ID NO: 1,

(ii) the N-terminus is identical to or corresponds to amino acid position 222 or higher and the C-terminus is identical to or corresponds to amino acid position 511 or lower of the amino acid sequence of PB2 according to SEQ ID NO: 2, or

(iii) wherein the N-terminus is identical to or corresponds to amino acid position 227 or higher and the C-terminus is identical to or corresponds to amino acid position 528 or lower of the amino acid sequence of PB2 according to SEQ ID NO: 3

and variants thereof, which retain the ability to associate with an RNA cap or analog thereof.

5. The polypeptide fragment of claim 4, wherein said polypeptide fragment has or corresponds to an amino acid sequence selected from the group of amino acid sequences according to SEQ ID NO: 4 to 13 and variants thereof, which retain the ability to associate with an RNA cap or analog thereof.

6. A complex comprising the polypeptide fragment of claim 1 and a RNA cap or analog thereof.

7. The complex of claim 6, wherein the cap analog is selected from the group consisting of m⁷G, m⁷GMP, m⁷GTP, m⁷GpppG, m⁷GpppGm, m⁷GpppA, m⁷GpppAm, m⁷GpppC, m⁷GpppCm, m⁷GpppU, and m⁷GpppUm.

8. The complex of claim 6, wherein said polypeptide fragment consists of an amino acid sequence according to SEQ ID NO: 11 and said cap analog is m⁷GTP, having the structure defined by the structure coordinates as shown in FIG. 18.

9. The complex of claim 8, wherein said complex has a crystalline form with space group C222i and unit cell dimensions of a=9.2 nm, b=9.4 nm; c=22.0 nm (±0.3 nm)

10. The complex of claim 8, wherein the crystal diffracts X-rays to a resolution of 3.0 A or higher, preferably 2.4 A or higher.

11. An isolated polynucleotide coding for an isolated polypeptide of claim 1.

12. A recombinant vector comprising said isolated polynucleotide of claim 11.

13. A recombinant host cell comprising said isolated polynucleotide of claim 11.

14. A method for identifying compounds which associate with all or part of the RNA cap binding pocket of PB2 or the binding pocket of a PB2 polypeptide variant, comprising the steps of (a) constructing a computer model of said binding pocket defined by the structure coordinates of the complex of claim 8 as shown in FIG. 18;

(b) selecting a potential binding compound by a method selected from the group consisting of:

(i) assembling molecular fragments into said compound, (ii) selecting a compound from a small molecule database, and (iii) de novo ligand design of said compound;

(c) employing computational means to perform a fitting program operation between computer models of the said compound and the said binding pocket in order to provide an energy-minimized configuration of the said compound in the binding pocket; and

(d) evaluating the results of said fitting operation to quantify the association between the said compound and the binding pocket model, whereby evaluating the ability of said compound to associate with the said binding pocket.

15. The method of claim 14, wherein said binding pocket comprises amino acids Phe323, His357, and Phe404 of PB2 according to SEQ ID NO: 1 or amino acids corresponding thereto.

16. The method of claim 15, wherein said binding pocket further comprises amino acids Phe325, Phe330, and Phe363 of PB2 according to SEQ ID NO: 1 or amino acids corresponding thereto.

17. The method of claim 15, wherein said binding pocket further comprises amino acids Glu361, and Lys376 of PB 2 according to SEQ ID NO: 1 or amino acids corresponding thereto.

18. The method of claim 15, wherein said binding pocket further comprises amino acids Ser320, Arg332, Ser337, and Gln406

19. The method of claim 15, wherein said binding pocket further comprises amino acids Lys339, Arg355, Asn429, and His432 of PB2 according to SEQ ID NO: 1 or amino acids corresponding thereto.

20. The method of claim 14, wherein said binding pocket is defined by the structure coordinates of PB2 SEQ ID NO: 1 amino acids Phe323, His357, and Phe404 according to FIG. 18.

21. The method of claim 20, wherein said binding pocket is further defined by the structure coordinates of PB2 SEQ ID NO: 1 amino acids Phe325, Phe330, and Phe363 according to FIG. 18.

22. The method of claim 20, wherein said binding pocket is further defined by the structure coordinates of PB2 SEQ ID NO: 1 amino acids Glu361, and Lys376 according to FIG. 18.

23. The method of claim 20, wherein said binding pocket is further defined by the structure coordinates of PB2 SEQ ID NO: 1 amino acids Ser320, Arg332, Ser337, and Gln406 according to FIG. 18.

24. The method of claim 20, wherein said binding pocket is further defined by the structure coordinates of PB2 SEQ ID NO: 1 amino acids Lys339, Arg355, Asn429, and His432 according to FIG. 18.

25. The method of claim 20, wherein the binding pocket of a PB2 polypeptide variant has a root mean square deviation from the backbone atoms of the amino acids Phe323, His357, and Phe404 of said binding pocket of not more than 2.5 A.

26. The method of claim 14 comprising the further step of (e) synthesizing said compound and optionally formulating said compound or a pharmaceutically acceptable salt thereof with one or more pharmaceutically acceptable excipient(s) and/or carrier(s).

27. The method of claim 26 comprising the further step of (f) contacting said compound, said polypeptide fragment of claim 1 and a RNA cap or analog thereof to determine the ability of said compound to inhibit binding between said PB2 polypeptide fragment and said RNA cap or analog thereof.

28. A compound identifiable by the method of claim 14, under the provision that the compound is not m⁷G, m⁷GMP, m⁷GTP, m⁷GpppG, m⁷GpppGm, m⁷GpppA, m⁷GpppAm, m⁷GpppC, m⁷GpppCm, m⁷GpppU, m⁷GpppUm, 2-Amino-7-benzyl-9-(4-hydroxy-butyl)-1,9-dihydro-purin-6-one, T-705 or m⁷Gppp(N)_1-15, wherein N is A, Am, G, Gm, C, Cm, U or Um and is able to bind to the RNA cap binding pocket of PB2 or variant thereof.

29. A compound identifiable by the method of claim 14, under the provision that the compound is not m⁷G, m⁷GMP, m⁷GTP, m⁷GpppG, m⁷GpppGm, m⁷GpppA, m⁷GpppAm, m⁷GpppC, m⁷GpppCm, m⁷GpppU, m⁷GpppUm, 2-Amino-7-benzyl-9-(4-hydroxy-butyl)-1,9-dihydro-purin-6-one, T-705 or m⁷Gppp(N)i.)₅, wherein N is A, Am, G, Gm, C₅Cm, U or Um and is able to inhibit binding between the PB2 polypeptide, variant thereof or fragment thereof and the RNA cap or analog thereof.

30. A method for identifying compounds which associate with the RNA cap binding pocket of PB2 or binding pockets of PB2 polypeptide variants, comprising the steps of (i) contacting said polypeptide fragment of claim 1 with a test compound and (ii) analyzing the ability of said test compound to bind to PB2.

31. The method of claim 30, comprising the further step of adding a RNA cap or analog thereof.

32. The method of claim 31, wherein the ability of said test compound to bind to PB2 or a variant thereof in presence of said RNA cap or analog thereof or the ability of said test compound to inhibit binding of said RNA cap or analog thereof to PB2 or a variant thereof is analyzed.

33. The method of claim 31, wherein said RNA cap or analog thereof is added prior, concomitantly, or after addition of said test compound.

34. The method of claim 30 performed in a high-throughput setting.

35. The method of claim 30, wherein said test compound is a small molecule.

36. The method of claim 30, wherein said test compound is a peptide or protein.

37. The method of any of claims 26, 27, or 30 to 36, wherein said method further comprises the step of formulating said compound or a pharmaceutically acceptable salt thereof with one or more pharmaceutically acceptable excipient(s) and/or carrier(s).

38. A pharmaceutical composition producible according to the method of claim 27.

39. A compound identifiable by the method of any of claims 30 to 37, under the provision that the compound is not m⁷G, m⁷GMP, m⁷GTP, m⁷GpppG, m⁷GpppGm, m⁷GpppA, m⁷GpppAm, m⁷GpppC, m⁷GpppCm, m⁷GpppU, m⁷GpppUm, 2-Amino-7-benzyl-9-(4-hydroxy-butyl)-1,9-dihydro-purin-6-one, T-705 or m⁷Gppp(N)i.i₅, wherein N is A, Am, G, Gm, C, Cm, U or Um and is able to bind to the PB2 polypeptide, variant thereof or fragment thereof.

40. A compound identifiable by the method of any of claims 29 to 36, under the provision that the compound is not m⁷G, m⁷GMP, m⁷GTP, m⁷GpppG, m⁷GpppGm, m⁷GpppA, m⁷GpppAm, m⁷GpppC, m⁷GpppCm, m⁷GpppU, m⁷GpppUm, 2-Amino-7-benzyl-9-(4-hydroxy-butyl)-1,9-dihydro-purin-6-one, T-705 or m⁷Gppp(N)i.i₅, wherein N is A, Am, G₅Gm, C, Cm, U or Um, and is able to inhibit binding between the PB2 polypeptide, variant thereof or fragment thereof and the RNA cap or analog thereof.

41. An antibody directed against the RNA cap binding domain of PB2.

42. The antibody of claim 41, wherein said antibody recognizes a polypeptide fragment selected from the group of polypeptides defined by SEQ ID NO: 14 to 22.

43. Use of a compound according to claim 28, 29, 39, or 40, a pharmaceutical composition according to claim 36, or an antibody according to claim 41 or 42 for the manufacture of a medicament for treating, ameliorating, or preventing disease conditions caused by viral infections with negative-sense ssRNA viruses.

44. The use of claim 43, wherein said disease condition is caused by viral infections of the Mononegavirales order comprising the Bornaviridae, Filoviridae, Paramyxoviridae, and Rhabdoviridae families.

45. The use of claim 43, wherein said disease condition is caused by the Orthomyxoviridae, Arenaviridae, or Bunyaviridae families.

46. The use of claim 43, wherein said disease condition is caused by a virus selected from the group consisting of Borna disease virus, Marburg virus, Ebola virus, Sendai virus, Mumps virus, Measles virus, Human respiratory syncytial virus, Turkey rhinotracheitis virus, Vesicular stomatitis Indiana virus, Nipah virus, Henda virus, Rabies virus, Bovine ephemeral fever virus, Infectious hematopoietic necrosis virus, Thogoto virus, Influenza A virus, Influenza B virus, Influenza C virus, Hantaan virus, Crimean-congo hemorrhagic fever virus, Rift Valley fever virus, and La Crosse virus.

47. The use of claim 43, wherein said disease condition is caused by a virus selected from the group consisting of Influenza A virus, Influenza B virus, Influenza C virus, Thogoto virus, and Hantaan virus.

48. A pharmaceutical composition producible according to the method of claim 37.